BARLETTA, FRANCESCO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 192
EU - Europa 180
AS - Asia 97
SA - Sud America 1
Totale 470
Nazione #
US - Stati Uniti d'America 188
SE - Svezia 80
CN - Cina 58
IT - Italia 40
SG - Singapore 25
RU - Federazione Russa 20
DE - Germania 11
FI - Finlandia 7
GB - Regno Unito 6
IR - Iran 6
CA - Canada 4
IN - India 4
BE - Belgio 3
IE - Irlanda 3
AT - Austria 2
CZ - Repubblica Ceca 2
NL - Olanda 2
SA - Arabia Saudita 2
GR - Grecia 1
HK - Hong Kong 1
MK - Macedonia 1
PH - Filippine 1
PL - Polonia 1
PY - Paraguay 1
UA - Ucraina 1
Totale 470
Città #
New York 40
Ashburn 26
Shanghai 23
Singapore 16
Lawrence 15
Princeton 15
Boardman 14
Milan 13
Moscow 10
Helsinki 5
Munich 4
Pune 4
Rome 4
Brussels 3
Dublin 3
Edinburgh 3
Los Angeles 3
Paderborn 3
Bethesda 2
Buffalo 2
Guangzhou 2
Jeddah 2
London 2
Palermo 2
Québec 2
Soverato Marina 2
Turin 2
Amsterdam 1
Asunción 1
Athens 1
Bengbu 1
Bonate Sopra 1
Borås 1
Council Bluffs 1
Crotone 1
Dalian 1
Freiburg im Breisgau 1
Gaithersburg 1
Genoa 1
Giussano 1
Jiaxing 1
Lappeenranta 1
Lucca 1
Manila 1
Naaldwijk 1
Nov Dojran 1
Ottawa 1
Padova 1
Quanzhou 1
Santa Clara 1
Seattle 1
Segrate 1
Sesto San Giovanni 1
Taizhou 1
Tehran 1
Toronto 1
Totale 251
Nome #
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 39
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 29
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 28
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 27
Prognostic impact of mitral regurgitation changes after TAVI 26
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 24
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 23
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 23
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 23
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 22
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 21
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 20
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate 20
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 19
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 19
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 18
Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis 18
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 18
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 18
Diagnostic and prognostic factors in patients with prostate cancer: A systematic review protocol 17
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 16
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 13
Extra- Mitral Valve Cardiac Involvement in Patients With Primary Mitral Regurgitation Undergoing Transcatheter Edgeto- Edge Repair 8
Impact of Pacemaker Implantation After Transcatheter Aortic Valve Replacement on Long-Term Survival in Patients With Bicuspid Aortic Valve 7
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 4
Prognostic Significance of Flail Mitral Leaflet in Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation 3
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 2
ASSOCIATION BETWEEN BRCA 1/2 POLYMORPHISMS AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 2
Totale 507
Categoria #
all - tutte 6.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 1 0 0 0 0 1 0 0
2020/20216 0 0 0 1 0 4 0 0 1 0 0 0
2021/202225 0 7 1 11 0 0 1 2 0 0 0 3
2022/2023141 37 29 12 8 3 15 5 18 1 0 6 7
2023/2024217 4 14 26 19 20 51 1 27 5 16 13 21
2024/2025116 40 15 13 22 26 0 0 0 0 0 0 0
Totale 507